General MedicationsORALStandard

QUININE SULFATE

Standard Dose

324MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview QUININE SULFATE is listed in Drugs@FDA under application 204372 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient QUININE SULFATE Form and strength CAPSULE;ORAL - 324MG Sponsor NOVAST LABS Submission history Latest submission status date: 2019-12-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview QUININE SULFATE is listed in Drugs@FDA under application 204372 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient QUININE SULFATE Form and strength CAPSULE;ORAL - 324MG Sponsor NOVAST LABS Submission history Latest submission status date: 2019-12-11 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.